Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
ATP binding enhances the activity of ClC-5, the transporter mutated in Dent disease, a disease affecting the renal proximal tubule. Previously, the ATP binding site was revealed in x-ray crystal structures of the cytoplasmic region of this membrane protein. Disruption of this site by mutagenesis (Y617A-ClC-5) reduced the functional expression and ATP-dependent regulation of the full-length transporter in Xenopus oocytes. However, insight into the conformational changes underlying ATP-dependent regulation is lacking. Here, we show that ATP binding induces a change in protein conformation. Specifically, small angle x-ray scattering experiments indicate that ATP binding promotes a clamp-like closure of the isolated ClC-5 carboxyl-terminal region. Limited proteolysis studies show that ATP binding induces conformational compaction of the carboxyl-terminal region in the intact membrane protein as well. In the context of fibroblasts and proximal tubule epithelial cells, disruption of the ATP binding site in full-length ClC-5 (Y617A-ClC-5) led to a defect in processing and trafficking out of the endoplasmic reticulum. These latter findings account for the decrease in functional expression previously reported for this ATP-binding mutant and prompt future study of a model whereby conformational compaction caused by ATP binding promotes biosynthetic maturation.
Bell,
Site-directed fluorescence studies of a prokaryotic ClC antiporter.
2006, Pubmed
Bell,
Site-directed fluorescence studies of a prokaryotic ClC antiporter.
2006,
Pubmed Bernocco,
Low resolution structure determination shows procollagen C-proteinase enhancer to be an elongated multidomain glycoprotein.
2003,
Pubmed Borbat,
Conformational motion of the ABC transporter MsbA induced by ATP hydrolysis.
2007,
Pubmed Dhani,
Evidence for a functional interaction between the ClC-2 chloride channel and the retrograde motor dynein complex.
2003,
Pubmed Drumm,
Inhibition of Na superset+/H superset+ exchange decreases albumin-induced NF-kappaB activation in renal proximal tubular cell lines (OK and LLC-PK1 cells).
2001,
Pubmed Du,
The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
2005,
Pubmed Dutzler,
X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity.
2002,
Pubmed Elvington,
Substrate-driven conformational changes in ClC-ec1 observed by fluorine NMR.
2009,
Pubmed Fan,
XPD helicase structures and activities: insights into the cancer and aging phenotypes from XPD mutations.
2008,
Pubmed Feng,
Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle.
2010,
Pubmed Gadsby,
The ABC protein turned chloride channel whose failure causes cystic fibrosis.
2006,
Pubmed Garboczi,
Rat liver mitochondrial ATP synthase. Effects of mutations in the glycine-rich region of a beta subunit peptide on its interaction with adenine nucleotides.
1990,
Pubmed Grand,
Novel CLCN5 mutations in patients with Dent's disease result in altered ion currents or impaired exchanger processing.
2009,
Pubmed
,
Xenbase Günther,
ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells.
1998,
Pubmed He,
Carboxy terminus splice variation alters ClC channel gating and extracellular cysteine reactivity.
2006,
Pubmed Hilge,
ATP-induced conformational changes of the nucleotide-binding domain of Na,K-ATPase.
2003,
Pubmed Hura,
Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS).
2009,
Pubmed Jentsch,
Chloride transport in the kidney: lessons from human disease and knockout mice.
2005,
Pubmed Landolt-Marticorena,
Substrate- and inhibitor-induced conformational changes in the yeast V-ATPase provide evidence for communication between the catalytic and proton-translocating sectors.
1999,
Pubmed Lloyd,
A common molecular basis for three inherited kidney stone diseases.
1996,
Pubmed
,
Xenbase Lloyd,
Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders.
1997,
Pubmed
,
Xenbase Lucas,
Purification, crystallization and preliminary X-ray diffraction analysis of the CBS-domain pair from the Methanococcus jannaschii protein MJ0100.
2008,
Pubmed Luckow,
Signals important for high-level expression of foreign genes in Autographa californica nuclear polyhedrosis virus expression vectors.
1988,
Pubmed Markovic,
The structure of the cytoplasmic domain of the chloride channel ClC-Ka reveals a conserved interaction interface.
2007,
Pubmed Meyer,
Nucleotide recognition by the cytoplasmic domain of the human chloride transporter ClC-5.
2007,
Pubmed
,
Xenbase Meyer,
Crystal structure of the cytoplasmic domain of the chloride channel ClC-0.
2006,
Pubmed Mohammad-Panah,
The chloride channel ClC-4 contributes to endosomal acidification and trafficking.
2003,
Pubmed Mohammad-Panah,
An essential role for ClC-4 in transferrin receptor function revealed in studies of fibroblasts derived from Clcn4-null mice.
2009,
Pubmed Moncoq,
SAXS study of the PIR domain from the Grb14 molecular adaptor: a natively unfolded protein with a transient structure primer?
2004,
Pubmed Picollo,
Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5.
2005,
Pubmed Piwon,
ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease.
2000,
Pubmed Putnam,
X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution.
2007,
Pubmed Riek,
Structural properties of AMP-activated protein kinase: dimerization, molecular shape, and changes upon ligand binding.
2008,
Pubmed Scheel,
Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins.
2005,
Pubmed
,
Xenbase Schulz,
The G215R mutation in the Cl-/H+-antiporter ClC-7 found in ADO II osteopetrosis does not abolish function but causes a severe trafficking defect.
2010,
Pubmed Segel,
Transient dimer in the refolding kinetics of cytochrome c characterized by small-angle X-ray scattering.
1999,
Pubmed Senior,
The catalytic cycle of P-glycoprotein.
1995,
Pubmed Sharom,
Spectroscopic and biophysical approaches for studying the structure and function of the P-glycoprotein multidrug transporter.
1998,
Pubmed Shin,
Superoxide dismutase from the eukaryotic thermophile Alvinella pompejana: structures, stability, mechanism, and insights into amyotrophic lateral sclerosis.
2009,
Pubmed Stratford,
The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
2007,
Pubmed Wellhauser,
Nucleotides bind to the C-terminus of ClC-5.
2006,
Pubmed Wellhauser,
A small-molecule modulator interacts directly with deltaPhe508-CFTR to modify its ATPase activity and conformational stability.
2009,
Pubmed Wrong,
Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance.
1994,
Pubmed Yamagata,
Hexameric structures of the archaeal secretion ATPase GspE and implications for a universal secretion mechanism.
2007,
Pubmed Zifarelli,
Intracellular regulation of human ClC-5 by adenine nucleotides.
2009,
Pubmed
